The role of guanylyl cyclases in the permeability response to inflammatory mediators in pial venular capillaries in the rat

Journal of Physiology

Volumn 540, Issue 1, 2002, Pages 209-218

  Sarker, M H ^a   Fraser, P A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC GMP; AUTACOID; BRADYKININ; BRADYKININ B2 RECEPTOR; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; HISTAMINE AGONIST; HISTAMINE H2 RECEPTOR; HS 142 1; KT 5823; LEUKOTRIENE D4; LY 85353; METHYLENE BLUE; N(G) METHYLARGININE; NATRIURETIC FACTOR; NITROUS OXIDE; PEPTIDE HORMONE RECEPTOR BLOCKING AGENT; PHOSPHODIESTERASE INHIBITOR; UNCLASSIFIED DRUG; ZAPRINAST; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; DIMAPRIT; NATRIURETIC PEPTIDE TYPE C; NITRIC OXIDE;

ARTICLE; BLOOD VESSEL OCCLUSION; BRAIN CAPILLARY; BRAIN EDEMA; CAPILLARY PERMEABILITY; CONTROLLED STUDY; INFLAMMATION; MEDIATOR RELEASE; NONHUMAN; PATHOPHYSIOLOGY; PIA MATER; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL TISSUE; DOSE RESPONSE; EC50; FEMALE; MALE; PROTEIN FUNCTION; VENULE;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD-BRAIN BARRIER; BRADYKININ; BRAIN EDEMA; CAPILLARIES; CAPILLARY PERMEABILITY; CYCLIC GMP; DIMAPRIT; FEMALE; GUANYLATE CYCLASE; HISTAMINE; HISTAMINE AGONISTS; INFLAMMATION MEDIATORS; MALE; NITRIC OXIDE; PIA MATER; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, HISTAMINE H2; VENULES;

EID: 0036554718     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2001.012912     Document Type: Article

References (51)

1. ABBOTT, N. J. (2000). Inflammatory mediators and modulation of blood-brain barrier permeability. Cellular and Molecular Neurobiology 20, 131-147
2. ADOLFSSON, J. L., OHD, J. F. & SJOLANDER, A. (1996). Leukotriene D4-induced activation and translocation of the G-protein alpha i3-subunit in human epithelial cells. Biochemical and Biophysical Research Communications 226, 413-419.
3. ALI, N., YOUSUFZAI, S. Y. & ABDEL-LATIF, A. A. (2000). Activation of particulate guanylate cyclase by adrenomedullin in cultured SV-40 transformed cat iris sphincter smooth muscle (SV-CISM-2) cells. Cell Signalling 12, 491-498.
4. ARNHOLD, S., ANTOINE, D., BLASER, H., BLOCH, W., ANDRESSEN, C. & ADDICKS, K. (1999). Nitric oxide decreases microvascular permeability in bradykinin stimulated and nonstimulated conditions. Journal of Cardiovascular Pharmacology 33, 938-947.
5. BARTON, M., BENY, J. L., D'USCIO, L. V., WYSS, T., NOLL, G. & LUSCHER T. F. (1998). Endothelium-independent relaxation and hyperpolarization to C-type natriuretic peptide in porcine coronary arteries. Journal of Cardiovascular Pharmacology 31, 377-383.
6. BRUNNER, F. & WOLKART, G. (2001). Endothelial NO/cGMP system contributes to natriuretic peptide-mediated coronary and peripheral vasodilation. Microvascular Research 61, 102-110.
7. CAMBRIDGE, H. & BRAIN, S.D. (1995). Mechanism of bradykinin-induced plasma extravasation in the rat knee joint. British Journal of Pharmacology 115, 641-647.
8. CHERRY, P. D., FURCHGOTT, R. F., ZAWADZKI, J. V. & JOTHIANANDAN, D. (1982). Role of endothelial cells in relaxation of isolated arteries by bradykinin. Proceedings of the National Academy of Sciences ofthe USA 79, 2106-2110.
9. CHI, O. Z., Liu, X. & WEISS, H. R. (1999). Effects of cyclic GMP on microvascular permeability of the cerebral cortex. Microvascular Research 58, 35-40.
10. DRAIJER, R., ATSMA, D. E., VAN DER LAARSE, A. & VAN HINSBERGH, V. W. (1995). cGMP and nitric oxide modulate thrombin-induced endothelial permeability. Regulation via different pathways in human aortic and umbilical vein endothelial cells. Circulation Research 76, 199-208.
11. EASTON, A. S. & FRASER P. A. (1994). Variable restriction of albumin diffusion across inflamed cerebral microvessels. Journal of Physiology 475, 147-157.
12. EASTON, A. S. & FRASER P. A. (1998). Arachidonic acid increases cerebral microvascular permeability by free radicals in single pial microvessels of the anaesthetized rat. Journal of Physiology 507, 541-547.
13. FABIAN, G., SZABO, C. A., BOZO, B., GREENWOOD, J., ADAMSON, P., DELI, M. A., JOO, F., KRIZBAI, I. A. & SZUCS, M. (1998). Expression of G-protein subtypes in cultured cerebral endothelial cells. Neurochemistiy International 33, 179-185.
14. FÉLETOU, M., BONNARDEL, E. & CANET, E. (1996). Bradykinin and changes in microvascular permeability in the hamster cheek pouch: role of nitric oxide. British Journal of Pharmacology 118, 1371-1376.
15. FRASER, P. A. & DALLAS, A. D. (1990). Measurement of filtration coefficient in single cerebral microvessels of the frog. Journal of Physiology 423, 343-361.
16. FRASER, P. A. & DALLAS, A. D. (1993). Permeability of disrupted cerebral microvessels in the frog. Journal of Physiology 461, 619-632.
17. FROSSARD, N., LANDRY, Y., PAULI, G. & RUCKSTUHL, M. (1981). Effects of cyclic AMP- and cyclic GMP- phosphodiesterase inhibitors on immunological release of histamine and on lung contraction. British Journal of Pharmacology 73, 933-938.
18. FURCHGOTT, R. F. & VANHOUTTE, P. M. (1989). Endothelium-derived relaxing and contracting factors. FASEB Journal 3, 2007-2018.
19. GARTHWAITE, J., SOUTHAM, E., BOULTON, C. L., NIELSEN, E. B., SCHMIDT, K. & MAYER, B.(1995). Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Molecular Pharmacology 48, 184-188.
20. GRAIER, W. F., HOEBEL, B. G., PALTAUF-DOBURZYNSKA, J. & KOSTNER G. M. (1998). Effects of superoxide anions on endothelial Ca2+ signaling pathways. Arteriosclerosis Thrombosis Vascular Biology 18, 1470-1479.
21. GRAMMAS, P., GIACOMELLI, F., BESSERT, D. & WIENER, J. (1991). Angiotensin II and atrial natriuretic factor receptor interactions at the blood-brain barrier. Brain Research 562, 93-97.
22. i. American Journal of Physiology 274, H1865-1874
23. HEMPEL, A., NOLL, T., BACH, C., PIPER, H. M., WILLENBROCK, R., HOHNEL, K., HALLER, H. & LUFT F. C. (1998). Atrial natriuretic peptide clearance receptor participates in modulating endothelial permeability. American Journal of Physiology 275, H1818-1825
24. HOLSCHERMANN, H., NOLL, T., HEMPEL, A. & PIPER, H. M. (1997). Dual role of cGMP in modulation of macromolecule permeability of aortic endothelial cells. American Journal of Physiology 272, H91-98.
25. HUXLEY, V. H., TUCKER, V. L., VERBURG, K. M. & FREEMAN, R. H. (1987). Increased capillary hydraulic conductivity induced by atrial natriuretic peptide. Circulation Research 60, 304-307.
26. IJIOMA, S. C, CHALLISS, R. A. & BOYLE, J. P. (1995). Comparative effects of activation of soluble and particulate guanylyl cyclase on cyclic GMP elevation and relaxation of bovine tracheal smooth muscle. British Journal of Pharmacology 115, 723-732.
27. IMURA, R., SANO, T., GOTO, J., YAMADA, K. & MATSUDA, Y. (1992). Inhibition by HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin, of atrial natriuretic peptide-induced relaxation of isolated rabbit aorta through the blockade of guanylyl cyclase-linked receptors. Molecular Pharmacology 42, 982-990.
28. KAWADA, T., ISHIBASHI, T., SASAGE, H., KATO, K. & IMAI, S. (1994). Modification by LY 83583 and methylene blue of relaxation induced by nitric oxide, glyceryl trinitrate, sodium nitroprusside and atriopeptin in aortae of the rat, guinea-pig and rabbit. General Pharmacology 25, 1361-1371.
29. KOBAYASHI, H., UENO, S., TSUTSUI, M., OKAZAKI, M., UEZONO, Y., YANAGIHARA, N., YUHI, T. & IZUMI, F. (1994). C-type natriuretic peptide increases cyclic GMP in rat cerebral microvessels in primary culture. Brain Research 648, 324-326.
30. KOOK, H., RHEE, J. H., LEE, S. E., KANG, S. Y., CHUNG, S. S., CHO. K. W. & BAIK, Y. H. (1999). Activation of particulate guanylyl cyclase by Vibrio vulnificus hemolysin. European Journal of Pharmacology 365, 267-272.
31. 2+ influx. Biochemical Journal 330, 695-699.
32. 2+-dependent effects of bradykinin on the activity of particulate guanylate cyclase. Biomedica Biochimica Acta 48, 597-600.
33. LUO, D., DAS, S. & VINCENT, S. R. (1995). Effects of Methylene blue and LY83583 on neuronal nitric oxide synthase and NADPH-diaphorase. European Journal of Pharmacology 290, 247-251.
34. MARTIN, W., WHITE, D. G. & HENDERSON, A. H. (1988). Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells. British Journal of Pharmacology 93, 229-239
35. MICHEL, C. C. & CURRY, F. E. (1999). Microvascular permeability. Physiological Reviews 79, 703-761.
36. NAKANO, S., MATSUKADO, K. & BLACK, K. L. (1996). Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer Research 56, 4027-4031.
37. NAZARIO, B., HU, R. M., PEDRAM, A., PRINS, B. & LEVIN, E. R. (1995). Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells. Journal for Clinical Investigation 95, 1151-1157.
38. POTTER, L. R. & HUNTER, T. (2001). Guanylyl cyclase-linked natriuretic peptide receptors: structure and regulation. Journal of Biological Chemistry 276, 6057-6060.
39. RAMIREZ, M. M., QUARDT, S. M., KIM, D., OSHIRO, H., MINNICOZZI, M. & DURAN, W. N. (1995). Platelet activating factor modulates microvascular permeability through nitric oxide synthesis. Microvascular Research 50, 223-234.
40. RUIZ, E. & TEJERINA, T. (1998). Relaxant effects of L-citrulline in rabbit vascular smooth muscle. British Journal of Pharmacology 125, 186-192.
41. SARKER, M. H., EASTON, A. S. & FRASER, P. A. (1998). Regulation of cerebral microvascular permeability by histamine in the anaesthetized rat. Journal of Physiology 507, 909-918.
42. SARKER, M. H. & FRASER, P. A. (1998). Evidence that bradykinin increases cerebral microvascular permeability via cGMP generated independently from soluble guanylate cyclase in the anaesthetized rat. Journal of Physiology 506.P, 22P.
43. SARKER, M. H. & FRASER, P. A. (1999). Bradykinin induced calcium increase depends on free radical formation in pial venular capillaries. Journal of Vascular Research 36, 327.
44. SARKER, M. H., Hu, D.-E. & FRASER, P. A. (2000). Acute effects of bradykinin on cerebral microvascular permeability in the anaesthetized rat. Journal of Physiology 528, 177-187.
45. SCHMIDT, M. J., SAWYER, B. D., TRUEX, L. L., MARSHALL, W. S. & FLEISCH, J. H. (1985). LY83583: an agent that lowers intracellular levels of cyclic guanosine 3′,5′-monophosphate. Journal of Pharmacology and Experimental Therapeutics 232, 764-769.
46. SPORBERT, A., MERTSCH, K., SMOLENSKI, A., HASELOFF, R. F., SCHONFELDER, G., PAUL, M., RUTH, P., WALTER, U. & BLASIG, I. E. (1999). Phosphorylation of vasodilator-stimulated phosphoprotein: a consequence of nitric oxide- and cGMP-mediated signal transduction in brain capillary endothelial cells and astrocytes. Brain Research. Molecular Brain Research 67, 258-266.
47. TERADA, Y., TOMITA, K., YOSHIYAMA, N., SHIIGAI, T. & MARUMO, F. (1989). Leukotriene D4 inhibits atrial natriuretic factor-dependent cGMP production in rat glomerulus. American Journal of Physiology 256, F95-99.
48. VIGNE, P. & FRELIN, C. (1992). C-type natriuretic peptide is a potent activator of guanylate cyclase in endothelial cells from brain microvessels. Biochemical Biophysical Research Communications 183, 640-644.
49. WEI, E. P., KONTOS, H. A. & BECKMAN, J. S. (1996). Mechanisms of cerebral vasodilation by superoxide, hydrogen peroxide, and peroxynitrite. American Journal of Physiology 271, H1262-1266.
50. WEIH, M. K., WEIKERT, S., FREYER, D. & DIRNAGL, U. (1998). Chemiluminescence detection of nitric oxide production from rat cerebral cortical endothelial cells in culture. Brain Research. Brain Research Protocols 2, 175-182.
51. WENNBERG, P.W., MILLER, V. M., RABELINK, T. & BURNETT, J. C., JR (1999). Further attenuation of endothelium-dependent relaxation imparted by natriuretic peptide receptor antagonism. American Journal of Physiology 277, H1618-1621.